Executive Profile

Martin C. Münchbach Ph.D. Managing Director and Investment Advisor, BB Biotech Ventures G.P.

Age	Total Calculated Compensation	This person is connected to 3 Board Members in 3 different organizations across 5 different industries. See Board Relationships
41	--

Background

Dr. Martin C. Münchbach, Ph.D. serves as the Managing Director and Investment Advisor at BB Biotech Ventures G.P. Dr. Münchbach serves as a Partner at Bellevue Group and is responsible for venture capital investments. He was a Partner of NMT Management AG - New Medical Technologies. While with Bellevue and previously with HBM/NMT, Dr. Münchbach invested in several Biotech investments in Europe and the US, including, e.g., Actelion, Axovan, Arpida, Chemocentryx, GeminX, ... Glycart, ICAgen and Inspire. He served at Sanofi. He served as Manager of BioMedPartners AG. Before becoming a Venture Capitalist, Dr. Münchbach held positions in strategic marketing at Sanofi-Synthelabo. He serves as Director of Tioga Pharmaceuticals, Inc. He has been Director of Radius Health, Inc since May 2011. He has been Director of BioVascular, Inc since February 2008. He served as Director of Optimer Pharmaceuticals, Inc from December 2005 to August 01, 2008. Dr. Münchbach holds a Ph.D. in Protein Chemistry, M.Sc. in Biochemistry and Master in Economics from Swiss Federal Institute of Technology (ETH), Zurich.

Corporate Headquarters Seestrasse 16 Zürich, -- 8700 Switzerland Phone: 41 44 267 67 00 Fax: 41 44 267 67 01 Board Members Memberships Director Tioga Pharmaceuticals, Inc. 2005-2008 Former Director Optimer Pharmaceuticals, Inc. 2008-Present Director BioVascular, Inc. 2011-Present Director and Member of Audit Committee Radius Health, Inc. Education PhD Eidgenössische Technische Hochschule Zürich Master's Degree Eidgenössische Technische Hochschule Zürich Unknown/Other Education Eberhard Karls Universität Tübingen Other Affiliations NMT Management AG - New Medical Technologies Sanofi Optimer Pharmaceuticals, Inc. Eidgenössische Technische Hochschule Zürich Eberhard Karls Universität Tübingen BioMedPartners AG Radius Health, Inc. Tioga Pharmaceuticals, Inc. BioVascular, Inc. BB Biotech Ventures II BB Biotech Ventures III

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.